Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study

被引：0
|
作者：
Annmarie Butare [1 ]
Tia Sutton [1 ]
Elizabeth Kantzler [1 ]
Katie N. Kennedy [2 ]
Dmitry Tumin [3 ]
Michael D. Honaker [4 ]
机构：
[1] Carolina University,Department of Surgery, Brody School of Medicine at East
[2] Brody School of Medicine at East Carolina University,Department of Hematology and Oncology
[3] East Carolina University Brody School of Medicine,Department of Academic Affairs
[4] East Carolina University,Department of Surgery, Division of Surgical Oncology, Division of Surgical Oncology
来源：
Journal of Gastrointestinal Cancer | 2025年 / 56卷 / 1期
关键词：
Adjuvant chemotherapy; Stage II colon cancer; High risk;
D O I：
10.1007/s12029-025-01186-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [2] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Chandhoke, Gursimran
    Wei, Xuejiao
    Nanji, Sulaiman
    Biagi, James
    Peng, Yingwei
    Krzyzanowska, Monika
    Mackillop, William J.
    Booth, Christopher M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2529 - 2538
  • [3] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Gursimran Chandhoke
    Xuejiao Wei
    Sulaiman Nanji
    James Biagi
    Yingwei Peng
    Monika Krzyzanowska
    William J. Mackillop
    Christopher M. Booth
    Annals of Surgical Oncology, 2016, 23 : 2529 - 2538
  • [4] Adjuvant chemotherapy for stage II colon cancer: the prognostic value of high-risk features
    Cheong, C.
    Suh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [6] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [7] A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers
    Phelip, J. M.
    Molinie, F.
    Delafosse, P.
    Launoy, G.
    Tretarre, B.
    Bara, S.
    Buemi, A.
    Velten, M.
    Danzon, A.
    Ganry, O.
    Bouvier, A. M.
    Grosclaude, P.
    Faivre, J.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (02): : 144 - 149
  • [8] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
    Koebrugge, B.
    Van Steenbergen, L. N.
    Lips, D. J.
    Lemmens, V. E.
    Van der Linden, H. C.
    Pruijt, H. F.
    Liefers, G.
    Van de Velde, C. J.
    Bosscha, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
  • [9] Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
    Cho, Jung Rae
    Lee, Keun-Wook
    Oh, Heung-Kwon
    Kim, Jin Won
    Kim, Ji-Won
    Kim, Duck-Woo
    Kim, Jee Hyun
    Kang, Sung-Bum
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 102 (05) : 271 - 280
  • [10] Elevated Carcinoembryonic Antigen Warrants Adjuvant Chemotherapy in High-risk Stage II Colon Cancer
    Wilson, Tanner B.
    Narayanan, Sowmya
    Khan, Sidrah
    Althans, Alison R.
    Paniccia, Alessandro
    Zureikat, Amer H.
    Kaltenmeier, Christof
    Lee, Kenneth K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 380 - 380
12345